# Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

> **NCT00002677** · PHASE1 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** tributyrin

## Key facts

- **NCT ID:** NCT00002677
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-08
- **Primary completion:** 2003-03
- **Final completion:** 2003-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002677, "Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*